SPV-30

N/A

Report date: 2024/12/06 13:56:10
NME

Base Information

Drug NameSPV-30
Drug Alias NameSPV-30
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsFatigue Syndrome, ChronicHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArkopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArkopharma
Active IndicationsN/A
Inactive IndicationsFatigue Syndrome, ChronicHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A